Search

everythinglearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Fipronil effectively treats Lynxacarus radovskyi in outdoor cats.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

The treatment combination is effective and generally safe for lung cancer.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The new delivery method for dutasteride is more effective and has fewer side effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Kuntai capsules combined with nilestriol tablets effectively reduce perimenopausal symptoms and improve hormone levels.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

The combination treatment showed a higher response rate but no significant survival benefits.

Ritlecitinib can help about 14,000 people with severe hair loss.